NUR 600 Assignment 3.2: Using the Seven Attributes with a Subjective Abnormal Finding
Sample Answer for NUR 600 Assignment 3.2: Using the Seven Attributes with a Subjective Abnormal Finding
Subjective abnormal finding: Nasal discharge
Location: Nasal cavity.
Quality: Thin, clear, and watery nasal secretions.
Quantity or severity: Copious amount of nasal secretions. The client uses 3-4 handkerchiefs per day.
Need a high-quality paper urgently?
We can deliver within hours.
Timing: The nasal discharge began three days ago. It is constant, and the client has to blow the nose every 5-10 minutes.
The setting in which it occurs: The nasal discharge occurs more when the patient is outdoors, but it still occurs when the client is indoors.
Aggravating or relieving factors: Aggravated by exposure to cold and being outdoors. The client associates the nasal discharge with winter. Relieved to some degree by taking warm water and OTC antihistamine syrup.
Associated manifestations: In addition to nasal discharge, the patient reports sneezing, nasal congestion, reduced sense of smell, eye redness, and itchy nose, eyes, ears, and palate.
ALSO READ:
NUR 600 Discussion 4.1: Sequence During a Physical Examination
NUR 600 Assignment 2.1: Patient History
NUR 600 Discussion 2.1: Creating a Positive Interview Experience
NUR 600 Assignment 3.1: Review of Systems (ROS) Documentation
NUR 600 Assignment 4.2: Assessment of the HEENT System Write-Up
NUR 600 Discussion 5.1: Lung Diagnoses
NUR 600 Assignment 5.2: Assessment of the Thorax and Lungs
NUR 600 Discussion 6.1: Cardiovascular Diagnoses
NUR 600 Assignment 6.3 Assessment of the Cardiovascular System Write-Up
NUR 600 Discussion 7.1 Common and Less-Common Diagnoses for the Breasts and Abdomen
NUR 600 Discussion 8.1: Common and Less-Common Diagnoses for the Neurologic System
NUR 600 Assignment 8.2: Assessment of the Peripheral Vascular and Nervous Systems Write-Up
NUR 600 Assignment 9.1: Iatrogenic Hymenal Case Study Write-Up
NUR 600 Discussion 10.1: Musculoskeletal System Diagnoses
NUR 600 Assignment 10.2: Musculoskeletal and Neurological Write-Up
NUR 600 Discussion 11.1 Crucial Conversations
NUR 600 Assignment 11.2: Writing a SOAP Note
NUR 600 Module 3 Discussion Drug Therapy & Treatments for Cardiovascular and Hematologic Disorders
Module 3 Discussion: Drug Therapy and Treatments for Cardiovascular and Hematologic Disorders
Question 1: Drug Therapy for Hypertension Goals and the Different Antihypertensive Treatment
One of the goals of hypertension drug therapy is lowering the blood pressure levels to the normal levels, reducing complications chances like kidney failure cardiovascular diseases amongst others. Significantly, lowering of the blood pressures levels is helpful for lowering risks of cardiovascular for health condition (Khalil & Zeltser, 2023). Systolic blood pressure maintenance of below 130mm Hg have been pinpointed to prevent complications amongst patients, promoting desirable health outcomes (Khalil & Zeltser, 2023). The other goal entails cardiovascular health improvement. Taking hypertension drug therapy has been associated with lowering of the blood pressure levels, impacting cardiovascular health. Through this, increased mortality rates linked with hypertension will be prevented and desirable health outcomes achieved (Khalil & Zeltser, 2023).
Predominantly, antihypertensive treatment is essential for desirable health outcomes to be achieved. One of the antihypertensive treatment involves thiazide diuretics. Typically, thiazide together thiazide like diuretics are regarded as the hypertension treatment first line (Khalil & Zeltser, 2023). Findings from studies have established that prescription of thiazide like diuretics for hypertension is more potent compared to hydrochlorothiazide. The other treatment is the calcium channel blockers. This form of treatment is highly recommended by the JNC8 guidelines to be useful as the first treatment line by its self or when combined with other antihypertensive amongst all patients with hypertension, despite their race and age (Khalil & Zeltser, 2023). however, this treatment is not recommended for patients with chronic kidney issues. Another treatment is the ACE inhibitors and ARNs. This medication is regarded as the suitable treatment choice, preferably with kidney failures and heart failure (Khalil & Zeltser, 2023).
Question 2: Arrhythmias and their Treatment
Supraventricular tachycardia (SVT) is a form arrhythmia that originates above the atrioventricular node and is defined accordingly by the narrow complex that is more than 100 beats every minute (Patti & Ashurst, 2022). The treatment for this form of arrhythmia involves prescription and administration of medications like adenosine. In addition, ventricular tachycardia (VT) is also an arrhythmias regarded to be life threatening. In addition, it is a ventricular arrhythmia complex origin defined highly by either tree or more consecutive at more 100 beats per minute rate (Foth et al., 2023). The treatment incorporate administration of antiarrhythmic.
Question 3: Atrial Fibrillation
Atrial fibrillation is regarded as the cardiac arrhythmia common form. Typically, atrial fibrillation is associated with abnormal electrical activity in the heart’s atria resulting in them to undergo fibrillation (Nesheiwat et al., 2023). In most instances, atrial fibrillation is shaped by tachyarrhythmia, implying the fast heart rate. Significantly atrial fibrillation is the primary cause of stroke and its risk factors involve high blood pressure, advanced age and congenital heart disease (Nesheiwat et al., 2023). Treatment for atrial fibrillation comprise cardioversion, anticoagulation, ablation and rhythm control medication.
Question 4: Types of Anemia, Causes, Symptoms and Treatment Options
One type of anemia is iron deficiency anemia. It is caused by iron insufficiency within the body resulting in reduced red blood cells production (Cafasso, 2023). Common symptoms associated with iron deficiency anemia involve weakness, pale skin, breath shortness, and fatigue. It can be treated though ensuring that the iron deficiency underlying cause have been addressed. In addition, supplementation can be recommended.
Another form is hemolytic anemia. It is primarily caused by the red blood cells destruction, increment in hemoglobin catabolism and reduced hemoglobin levels (Baldwin et al., 2023). Causes associated with their health condition comprise infections and autoimmune disorders (Baldwin et al., 2023). The primary symptoms comprise breath shortness, fatigue, dark urine and jaundice. Significantly, the treatment highly depends on the underlying causes and may involve blood transfusion and medications (Baldwin et al., 2023).
References
Baldwin, C., Pandey, J., & Olarewaju, O. (2023, July 24). Hemolytic anemia – StatPearls – NCBI bookshelf. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK558904/
Cafasso, J. (2023, February 6). Iron-deficiency anemia: Symptoms, causes, and more. Healthline. https://www.healthline.com/health/iron-deficiency-anemia
Foth, C., Gangwani, M. K., Ahmed, I., & Alvey, H. (2023, July 30). Ventricular tachycardia – StatPearls – NCBI bookshelf. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK532954/
Khalil, H., & Zeltser, R. (2023, May 8). Antihypertensive medications – StatPearls – NCBI bookshelf. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK554579/
Nesheiwat, Z., Goyal, A., & Jagtap, M. (2023, April 26). Atrial fibrillation – StatPearls – NCBI bookshelf. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK526072/
Patti, L., & Ashurst, J. V. (2022, August 8). Supraventricular tachycardia – StatPearls – NCBI bookshelf. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK441972/